ASC2ESCALATE: A phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI) Meeting Abstract
| Authors: | Sasaki, K.; Mauro, M.; Levy, M. Y.; Atallah, E. L.; Koller, P. B.; Maegawa, R.; Damon, A.; Kumar, J.; Khan, M.; Cortes, J. E. |
| Abstract Title: | ASC2ESCALATE: A phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6784 |
| End Page: | 6786 |
| Language: | English |
| ACCESSION: | WOS:000893223206356 |
| DOI: | 10.1182/blood-2022-167044 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
